Contract Research Services | SRI International

Toggle Menu

Contract Research Services

Maximize investment dollars, minimize risk with our research services

Outsourcing R&D can play an important role in enhancing capacity and strengthening expertise. SRI Biosciences partners with clients to seamlessly integrate basic research, drug discovery, and nonclinical and clinical development.

We provide research and services that span all stages of drug discovery and preclinical development leading to human clinical trials. Your goals are our priority. We combine outstanding customer service with a commitment to scientific excellence through best-in- class R&D.

Learn how our specialized services for contract R&D can help you improve operating and infrastructure efficiency. Browse the services highlighted here, or contact us through the form below to discuss your specific needs.

Cognitive Science Research

SRI's translational neurosciences research laboratory provides investigative studies of complex cognitive processes utilizing customized, validated models that support research from rodent studies to human clinical trials. SRI manages a state-of-the-art laboratory that employs translational models to better understand complex biological and neurological disease mechanisms—and ultimately accelerate and minimize drug discovery risks and development to accelerate time to market for new treatments.

Circulating Tumor Cell Testing Services

Our FASTcell™ testing services deliver rapid, sensitive, and specific characterization of CTCs in whole blood samples, giving cancer clinical researchers a vital new analytical testing tool. The underlying technology can accurately characterize CTCs from a number of cancers (including breast, lung, prostate, colorectal, and leukemia) through a wide array of customizable cancer-specific biomarkers.

Cancer Efficacy Evaluation Services

SRI’s in vivo efficacy testing services include a broad range of xenograft tumor models in mice, including SRI's customized patient derived cellular xenograft model - PDCellX™. PDCellX provides a more predictive model of human response in a variety of tissues and provides advantages such as custom biomarker and pharmacodynamic endpoint analysis and shorter tumor study timelines compared to standard PDX models.

Medicinal Chemistry Services

With extensive applied knowledge and experience, our medicinal chemistry and strategic guidance services can be applied at every stage of the drug discovery process (hit validation, hit-to-lead, and lead optimization) to help create and deliver effective candidates for further preclinical or clinical evaluations. Client investigators can also request specific services, such as custom synthesis and validated testing for physico-chemical, biological, and pharmacokinetic profiling, as well as custom assay development.

Formulation and Manufacturing (CMC) Services

SRI's preformulation and formulation services help optimize safety and efficacy in drug development. Our approach is customized according to each client’s program needs. Our drug formulation experience ranges from preparation of dose formulations for preclinical in vitro and in vivo safety studies, to design and manufacture of finished drug product dosage forms for clinical trials.

Phase I Clinical Trial Services

SRI is pioneering a new paradigm in "enriched" Phase 1 clinical trial services, seamlessly combining Phase 1 clinical trial services with strategic development support. Services are performed at our 16-bed, state-of-the-art facility ideally situated in Plymouth, Michigan between Ann Arbor and Detroit, and conveniently located near three major medical centers.

In Vivo Assay Research and Development Services

SRI Biosciences provides internationally recognized expertise and services through all stages of drug discovery and development. With state-of- the-art equipment and biomedical research facilities, we offer turnkey and customized In Vivo R&D Services, including animal models for research and drug discovery, identification of targets and mechanisms of action, efficacy, pharmacology and pharmacokinetics, and safety. Contact us through the form below for more information or to discuss your requirements.

Open/Close
ADME
  • Absorption and clearance
  • Excretion and mass balance
  • Interspecies comparative metabolism
  • Metabolite profile
  • Tissue distribution
Open/Close
Anxiety
  • Chemical-Induced Stress
  • Elevated Plus Maze
  • Elevated Zero Maze
  • Force Swim Test (Model of Stress or Depression)
  • Head Twitch Model
  • Light/Dark Chamber Test
  • Marble Burying
  • Open Field Test
  • Social Interaction
  • Three Chamber Test
Open/Close
Autimmune/Inflammation
  • Arthritis (collagen & Freund's adjuvant-induced)
  • Bleomycin-induced scleroderma
  • Colitis (dextran sulfate & DNBS-induced)
  • Delayed Type Hypersensitivity
  • Diabetes- spontaneous and streptozoticin
  • Experimental autoimmune encephalomyelitis (Multiple Sclerosis)
  • Imiquimod-induced psoriasis
  • Inflammatory Bowel Disease/Colitis (dextran sulfate & DNBS-induced)
  • Sepsis model (LPS challenge, cecal ligation/puncture)
Open/Close
Bacterial/Fungal Models
  • C. difficile-associated disease (CDAD) model
  • K. pneumoniae thigh infection model (IM; neutropenic/immunocompromised)
  • Listeriosis systemic model
  • Select Agent models
  • Sepsis model (LPS challenge, cecal ligation/puncture)
  • Streptococcus pneumoniae intratracheal challenge model
  • Superficial skin infection model (Staphylococcus aureus)
Open/Close
Cancer Efficacy Models
  • Angiogenesis with humanized stroma (human skin graft model)
  • Biodistribution in xenograft models
  • Combination cancer efficacy studies
  • Human tumor cell line derived murine xenograft models - orthotopic and subcutaneous
  • Humanized models
  • PDX models
  • Radiosensitization/radiotherapy
  • Syngeneic models
Open/Close
Cancer Pathology and Follow-On Studies
  • Angiongenesis (blood vessel density measurements)
  • Biochemical assays for target effectiveness
  • Biomarkers
  • Cellular hypoxia analysis
  • Circulating tumor cells (CTC)
  • Fluorescence imaging
  • Histology
  • Immunohistochemistry
  • Molecular biology assays for tissue analyses, building molecular probes, developing models, for enzymes, cytokines, other protein targets
Open/Close
Cognition/Learning/Memory
  • Associative Memory (Fear Conditioning, Passive Avoidance)
  • Attention/Vigilance (e.g, Five-Choice Serial Reaction Time)
  • Buried and Visible Pellet Assays - also for olfaction
  • Drug-Induced Cognitive Deficit
  • Executive Function (Object Retrieval)
  • Nest Building
  • Novel Object Recognition
  • Psychomotor Vigilence Test
  • Spatial Memory (Morris Water Maze)
  • Spatial Reference Memory
  • T-Maze
  • Working Memory (Radial Arm Maze)
Open/Close
Custom Service
  • Biomarker Discovery & Development
  • Customized Assay Development and Screening
  • Diagnostic Development
Open/Close
Developmental and Reproductive Toxicology
  • Androgenic assay
  • Antigonadotropin assay
  • Clauberg-McPhail endometrial proliferation
  • Embryo-fetal prenatal development —Segment II
  • Fertility and early embryonic development to implantation— Segment I
  • Fertility, Anti-fertility, and Contraception Studies
  • Microbicide testing
  • Perinatal and postnatal development, including maternal function—Segment III
  • Sperm motility & morphology
  • Toxicity to male fertility
Open/Close
Diabetes
  • Blood Glucose Testing (OGTT, IPGTT, IVCTT)
  • Continuous Monitoring of Drinking Water
  • Diabetes Rescue Model
  • Diabetic Neuropathy (STZ Induced)
  • Insulin Pellet and Device Implants to Measure Compound Delivery
  • Microsurgical Implant and Characterization of Medical Device Prototypes (i.e., glucose sensors)
  • Micturation Monitoring
  • Obesity
  • Type I Diabetes - Multiple Dose Stretozotocin (MD-STZ) Induced Diabetes
  • Type I Diabetes - Non-Obese Diabetic (NOD) mouse model of spontaneous Type I Diabetes (T1D) autoimmune disease
  • Type II Diabetes - Alloxan Induced Diabetes
  • Type II Diabetes - Streptozotocin (STZ) Induced Diabetes
  • Western Diet Diabetic model
Open/Close
Drug Abuse Liability/Addiction
  • Alcohol Use/Dependence
  • Behavioral Assessment following Repeated Drug Administration (i.e., stereopathies)
  • DJ-Dopamine Transporter Interaction in Models of Addiction (transgenic susceptibility models)
  • Drug Reward
  • Drug-Dependence Models (Withdrawal-Induced Behaviors )
  • Evaluation of Receptor Targets for Drug Abuse Medications and Non-Addicting Analgesics
  • Locomotor Sensitization
  • Self-Administration Paradigm (including nicotine)
Open/Close
Electrophysiology
  • EEG
  • Electrode Arrays
  • Intracellular Recordings
  • Local Field Potentials
  • Multiple Unit Recordings
  • Optigenetics
  • Single Unit Recordings
  • Slice Recordings
  • Stimulating Electrodes
Open/Close
Epilepsy
  • Chemical-Induced Seizures
  • Electrically-Induced Seizures
  • Organ Microdialysis
Open/Close
Genetic Toxicology
  • Biodistribution, persistence, integration
  • Customized, molecular endpoints
  • FISH cytogenetic analysis
  • In vivo chromosome aberration
  • In vivo micronucleus
  • Microarray analysis
  • Mutation analysis
  • Quantitative PCR and RT-PCR
  • Transgenic mutagenesis assays
  • Unscheduled DNA synthesis
Open/Close
Imaging Models
  • Bioluminescent (IVIS® Lumina)
  • Echocardiography
  • Fluorescent (IVIS® Lumina)
  • MRI
  • Near-infrared (IVIS® Lumina)
  • Ultrasound
  • X-ray
Open/Close
Immune Function
  • Adjuvant efficacy
  • Assessment of immunogenicity (cellular, humoral, innate)
  • Biomarkers
  • Host gene expression (mRNA) for immune response and antiviral related genes
  • Potency assays
  • Vaccine efficacy
Open/Close
Immunotoxicity
  • Antibody Forming Cell (AFC) assay
  • Autoimmune disease models
  • Host resistance (including L. monocytogenes, influenza and cancer)
  • Hypersensitivity (LLNA and MEST)
  • Immune cell function (ELISPOT, CTL, NK function, macrophage phagocytosis)
  • Immunopathology
  • Immunophenotyping
Open/Close
Infectious Disease Models
  • Aerosol and Contact Transmission
  • Co-Infections
  • Host Resistance Models (Influenza, Listeria)
  • Host Response Studies
  • Resistance Monitoring
  • Secondary Infections
  • Synergy (drug combination)
  • Therapeutic Efficacy
  • Therapeutic Safety
Open/Close
Microdialisis
  • Monitoring Neurotransmitters in Freely Behaving Animals
  • Muscle Microdialysis
  • Neurotransmittor Analysis
  • Pharmacokinetic/Pharmacodynamic Determinations
  • Simultaneous Microdialysis and Behavioral Monitoring
  • Skin Microdialysis
Open/Close
Motor Function
  • Beam Test
  • Catalepsy
  • Catalepsy (Bar Test)
  • Dyskinesias
  • Extrapyramidal Symptoms
  • Grip Strength
  • Locomotion
  • Locomotor Activity (telemetry, beam breaking, wheel running)
  • Open Field
  • Parkinson's dyskinesia ratings
  • Parkinson's motor testing
  • Rearing and Climbing
  • Rotorod
  • Sedation
  • Stride length
  • Videotracking
Open/Close
Neurological Disorders
  • Alzheimer's Disease
  • Amyotrophic Lateral Sclerosis
  • Gaucher's disease
  • Huntington's Disease
  • Mechanisms for prevention/intervention/neural repair
  • Narcolepsy
  • Neurodegenerative disease modeling (toxicant/transgenic systems)
  • Nicotine and Neuroprotection in Parkinson Mouse Model
  • Parkinson's Disease
Open/Close
NHP Translational Models
  • Antidepressant Efficacy
  • Associative Learning (e.g., Paired-Associate Learning)
  • Catalepsy
  • Dyskinesias
  • Extrapyramidal Symptoms
  • Eye-tracking
  • Impulsivity
  • Locomotion
  • Object Retrieval
  • Sedation
  • Spatial Working Memory (e.g., Self-Ordered Spatial Search)
  • Sustained Attention (e.g., Continuous Performance Test)
  • Working Memory (e.g., Delayed Match-to-Sample)
Open/Close
Other Endpoints/Capabilities
  • Circadian rhythms assessment
  • Custom neurosurgical capabilities
  • Electromyogram (EMG) recordings
  • Functional Observation Battery
  • ICV, intrathecal, multiple drug delivery
  • Infra-red digital video recording
  • Quantitative EEG analysis
  • Safety Pharmacology
  • Sleep/wake recordings and analysis
  • Stereotaxic Implants
  • Surgical implant/catheterization of slow release pellets/devices/pumps
Open/Close
Pain/Analgesia
  • Chemical-Induced Inflammatory Pain (Complete Freund's Adjuvant, Carrageenan)
  • Chronic Constriction Injury (CCI)
  • Cold-plate and Hot-plate/Radiant Heat Test (Paw Withdrawal)
  • Formalin Test (Phase I and II responses)
  • Orofacial Formalin Test
  • Plantar Test (Hargreave's method; radiant heat stimulus)
  • Receptor Profiles
  • Spinal Nerve Ligation (SNL, Chung Model)
  • Streptozotocin (STZ) Induced Diabetic Neuropathy
  • Tail Flick Test (radiant heat or warm water immersion)
  • Von Frey Test
Open/Close
Pharmacokinetic and Pharmacodynamic Analyses
  • Bioavailability
  • Bioequivalence
  • Metabolite identification
  • Pharmacokinetics
Open/Close
Psychiatric Disorders
  • Anti-Depression Efficacy
  • Drug-Induced Hyperactivity & Hypoactivity
  • Drug-Induced Psychosis
  • Drug-Induced Rearing and Climbing
  • Headshake/Head Twitch Model
  • Impulsivity
  • PrePulse Inhibition (PPI) of Acoustic Startle
Open/Close
Radiation Models
  • Radiation biomarkers
  • Radiation protection
  • Radiosensitization
  • Radiotherapy
Open/Close
Sleep, Circadian Rhythm
  • Circadian rhythms assessment
  • Electromyogram (EMG) recordings
  • Infra-red digital video recording
  • Narcolepsy models
  • Sleep/wake recordings and analysis
Open/Close
Specialized Safety Assessments
  • Aging animal studies
  • Biological product testing
  • Cardiac biomarkers: B-type natriuretic peptide, troponin I, myoglobin
  • Cardiovascular evaluation
  • Combination products and delivery systems
  • DNA/RNA biodistribution, persistence, integration
  • Immune endpoints of irritation
  • Immunogenicity
  • Immunotoxicology
  • Irritation and sensitization
  • Learning and memory evaluations
  • Local lymph node assay
  • Medical device safety evaluation
  • Medical imaging products
  • Micronucleus evaluation
  • Neonatal and juvenile animal studies
  • Neurobehavioral evaluation
  • Pharmacodynamics
  • Proteomic assessments
  • Radiation studies
  • Safety evaluation of cell-based therapeutics
  • Specialized biomarkers
  • Toxicogenomics assessment
  • Toxicokinetic analysis
  • Vaccine safety
Open/Close
Toxicology and Safety
  • Acute, subchronic, and chronic toxicity
  • Dose escalation, range-finding, maximum tolerated dose (MTD)
  • Lifetime and carcinogenic potential
  • Transgenic carcinogenicity in mice
Open/Close
Toxin Models
  • Toxin Potency and Therapeutic Efficacy
Open/Close
Viral Models
  • Alphaviruses (WEE/EEE/VEE/Chik)
  • Arenaviruses (Pichinde', Tacaribe', Tamiami)
  • Dengue
  • Hantavirus (Andes)
  • Human coronaviruses (not MERS/SARS)
  • Human Herpes virus (HSV-1, HSV-2)
  • Human metapneumovirus
  • Measles virus
  • MERS-CoV
  • Monkeypox virus (Pox)
  • Parainfuenza virus
  • Rabbit pox virus
  • Respiratory syncytial virus
  • SARS-CoV
  • Vaccinia virus (pox), Modified Vaccinia Ankara (MVA)
  • West Nile virus
  • Yellow fever virus

Find out more about SRI's proven, disciplined approach to innovation. Fill out the form or call SRI Biosciences at (866) 451-5998 (toll-free in the U.S.).

Horizontal Tabs

Public Sector
Commercial
Education

*Required field